Sanctuary Advisors LLC Purchases Shares of 24,592 The Beauty Health Company (NASDAQ:SKIN)

Sanctuary Advisors LLC bought a new position in The Beauty Health Company (NASDAQ:SKIN) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 24,592 shares of the company’s stock, valued at approximately $47,000.

Several other institutional investors also recently modified their holdings of SKIN. Caprock Group LLC bought a new stake in shares of Beauty Health in the second quarter worth approximately $38,000. SageView Advisory Group LLC bought a new stake in Beauty Health in the first quarter worth $60,000. Susquehanna Fundamental Investments LLC bought a new stake in Beauty Health in the second quarter worth $105,000. 180 Wealth Advisors LLC raised its stake in shares of Beauty Health by 25.3% in the second quarter. 180 Wealth Advisors LLC now owns 101,855 shares of the company’s stock valued at $187,000 after acquiring an additional 20,570 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Beauty Health in the first quarter valued at $200,000. 93.26% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

SKIN has been the topic of several recent analyst reports. Stifel Nicolaus reduced their price target on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a research note on Friday, July 26th. Piper Sandler reaffirmed an “underweight” rating and issued a $1.00 price target (down previously from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Finally, Canaccord Genuity Group dropped their target price on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating on the stock in a report on Monday, August 12th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $2.46.

Beauty Health Price Performance

Shares of Beauty Health stock opened at $1.60 on Tuesday. The Beauty Health Company has a 1 year low of $0.91 and a 1 year high of $5.17. The stock has a market cap of $198.43 million, a price-to-earnings ratio of -1.93 and a beta of 0.94. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. The firm’s 50-day moving average is $1.54 and its two-hundred day moving average is $2.10.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). Beauty Health had a negative net margin of 22.86% and a negative return on equity of 4.57%. The firm had revenue of $90.60 million during the quarter, compared to the consensus estimate of $98.46 million. As a group, research analysts expect that The Beauty Health Company will post -0.2 earnings per share for the current fiscal year.

Insider Activity

In other news, Chairman Brent L. Saunders purchased 40,450 shares of the stock in a transaction dated Monday, August 12th. The shares were acquired at an average cost of $1.08 per share, for a total transaction of $43,686.00. Following the acquisition, the chairman now owns 5,921,769 shares of the company’s stock, valued at approximately $6,395,510.52. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 41.00% of the company’s stock.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.